Status:
COMPLETED
Improving Skin Cancer Management With Artificial Intelligence (04.17 SMARTI)
Lead Sponsor:
Melanoma and Skin Cancer Trials Limited
Collaborating Sponsors:
Monash University
Conditions:
Skin Cancer
Melanoma (Skin)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study is designed to be able to prove if the Molemap Artificial Intelligence (AI) algorithm can be used as a diagnostic aid in a clinical setting. This study will determine whether the diagnostic ...
Detailed Description
This is a pilot study which aims to establish whether artificial intelligence can be used as a diagnostic aid to improve diagnostic accuracy and outcomes in the specialist setting prior to conducting ...
Eligibility Criteria
Inclusion
- Patients attending the specialist dermatology clinics for skin cancer assessment or surveillance.
- Patients may or may not have a lesion of concern.
- Patients must have at least two lesions imaged during full skin examination by a dermatologist.
- Age greater than 18 years.
- Participant is willing and able to undertake investigation of suspicious lesion (e.g. skin biopsy).
Exclusion
- Patient does not give informed consent.
- Patient is unable or unwilling to have a full skin examination
- Patient has a known past or current diagnosis of cognitive impairment
Key Trial Info
Start Date :
October 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 30 2021
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04040114
Start Date
October 1 2019
End Date
May 30 2021
Last Update
August 19 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
The Alfred- Victorian Melanoma Service
Melbourne, Victoria, Australia, 3004
2
Skin Health Institute
Melbourne, Victoria, Australia, 3053